| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 4.40e-06 | 188 | 46 | 6 | GO:0005201 | |
| GeneOntologyMolecularFunction | calcium ion binding | 2.78e-04 | 749 | 46 | 8 | GO:0005509 | |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | ZNF500 KLF17 ZNF630 ZNF776 ZFP90 ZNF865 ZNF446 ZNF408 ZNF697 ZNF316 ZNF646 | 3.75e-04 | 1459 | 46 | 11 | GO:0000977 |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | ZNF500 KLF17 ZNF630 ZNF776 ZNF865 ZNF446 ZNF408 ZNF697 ZNF316 ZNF646 | 4.41e-04 | 1244 | 46 | 10 | GO:0000978 |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | ZNF500 KLF17 ZNF630 ZNF776 ZNF865 ZNF446 ZNF408 ZNF697 ZNF316 ZNF646 | 5.22e-04 | 1271 | 46 | 10 | GO:0000987 |
| GeneOntologyMolecularFunction | integrin binding | 6.98e-04 | 175 | 46 | 4 | GO:0005178 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | ZNF500 KLF17 ZNF630 ZNF776 ZFP90 ZNF446 ZNF408 ZNF697 ZNF316 ZNF646 | 1.18e-03 | 1412 | 46 | 10 | GO:0000981 |
| GeneOntologyMolecularFunction | transforming growth factor beta binding | 1.63e-03 | 26 | 46 | 2 | GO:0050431 | |
| GeneOntologyCellularComponent | extracellular matrix | LAMA5 SNED1 SLIT2 CFP LTBP3 ADAMTS8 HMCN1 EDIL3 ADAMTS2 LTBP4 FBN3 | 1.03e-07 | 656 | 45 | 11 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | LAMA5 SNED1 SLIT2 CFP LTBP3 ADAMTS8 HMCN1 EDIL3 ADAMTS2 LTBP4 FBN3 | 1.06e-07 | 658 | 45 | 11 | GO:0030312 |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | 1.59e-06 | 530 | 45 | 9 | GO:0062023 | |
| GeneOntologyCellularComponent | microfibril | 3.48e-04 | 13 | 45 | 2 | GO:0001527 | |
| Domain | EGF | LAMA5 SNED1 SLIT2 LTBP3 HMCN1 MEGF8 EDIL3 LTBP4 TMEM8B FBN3 PEAR1 | 6.90e-12 | 235 | 45 | 11 | SM00181 |
| Domain | EGF_1 | LAMA5 SNED1 SLIT2 LTBP3 HMCN1 MEGF8 EDIL3 LTBP4 TMEM8B FBN3 PEAR1 | 1.67e-11 | 255 | 45 | 11 | PS00022 |
| Domain | EGF-like_CS | LAMA5 SNED1 SLIT2 LTBP3 HMCN1 MEGF8 EDIL3 LTBP4 TMEM8B FBN3 PEAR1 | 2.14e-11 | 261 | 45 | 11 | IPR013032 |
| Domain | EGF_2 | LAMA5 SNED1 SLIT2 LTBP3 HMCN1 MEGF8 EDIL3 LTBP4 TMEM8B FBN3 PEAR1 | 2.53e-11 | 265 | 45 | 11 | PS01186 |
| Domain | EGF_Ca-bd_CS | 7.26e-11 | 97 | 45 | 8 | IPR018097 | |
| Domain | EGF_CA | 8.57e-11 | 99 | 45 | 8 | PS01187 | |
| Domain | ASX_HYDROXYL | 9.30e-11 | 100 | 45 | 8 | PS00010 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 1.49e-10 | 106 | 45 | 8 | IPR000152 | |
| Domain | EGF_3 | 1.78e-10 | 235 | 45 | 10 | PS50026 | |
| Domain | EGF-like_dom | 3.14e-10 | 249 | 45 | 10 | IPR000742 | |
| Domain | EGF_CA | 4.63e-10 | 122 | 45 | 8 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 5.27e-10 | 124 | 45 | 8 | IPR001881 | |
| Domain | - | ZNF500 ZNF200 KLF17 ZNF630 ZNF776 PRDM9 ZFP90 ZNF865 ZNF446 ZNF408 ZNF697 ZNF316 ZNF646 | 4.32e-09 | 679 | 45 | 13 | 3.30.160.60 |
| Domain | zf-C2H2 | ZNF500 ZNF200 KLF17 ZNF630 ZNF776 PRDM9 ZFP90 ZNF865 ZNF446 ZNF408 ZNF697 ZNF316 ZNF646 | 5.51e-09 | 693 | 45 | 13 | PF00096 |
| Domain | Znf_C2H2/integrase_DNA-bd | ZNF500 ZNF200 KLF17 ZNF630 ZNF776 PRDM9 ZFP90 ZNF865 ZNF446 ZNF408 ZNF697 ZNF316 ZNF646 | 5.61e-09 | 694 | 45 | 13 | IPR013087 |
| Domain | hEGF | 6.09e-09 | 28 | 45 | 5 | PF12661 | |
| Domain | ZINC_FINGER_C2H2_2 | ZNF500 ZNF200 KLF17 ZNF630 ZNF776 PRDM9 ZFP90 ZNF865 ZNF446 ZNF408 ZNF697 ZNF316 ZNF646 | 2.09e-08 | 775 | 45 | 13 | PS50157 |
| Domain | ZINC_FINGER_C2H2_1 | ZNF500 ZNF200 KLF17 ZNF630 ZNF776 PRDM9 ZFP90 ZNF865 ZNF446 ZNF408 ZNF697 ZNF316 ZNF646 | 2.15e-08 | 777 | 45 | 13 | PS00028 |
| Domain | Znf_C2H2-like | ZNF500 ZNF200 KLF17 ZNF630 ZNF776 PRDM9 ZFP90 ZNF865 ZNF446 ZNF408 ZNF697 ZNF316 ZNF646 | 2.86e-08 | 796 | 45 | 13 | IPR015880 |
| Domain | Znf_C2H2 | ZNF500 ZNF200 KLF17 ZNF630 ZNF776 PRDM9 ZFP90 ZNF865 ZNF446 ZNF408 ZNF697 ZNF316 ZNF646 | 3.27e-08 | 805 | 45 | 13 | IPR007087 |
| Domain | ZnF_C2H2 | ZNF500 ZNF200 KLF17 ZNF630 ZNF776 PRDM9 ZFP90 ZNF865 ZNF446 ZNF408 ZNF697 ZNF316 ZNF646 | 3.41e-08 | 808 | 45 | 13 | SM00355 |
| Domain | Growth_fac_rcpt_ | 8.62e-08 | 156 | 45 | 7 | IPR009030 | |
| Domain | TSP_1 | 4.09e-07 | 63 | 45 | 5 | PF00090 | |
| Domain | TB | 4.54e-07 | 7 | 45 | 3 | PF00683 | |
| Domain | TSP1 | 4.79e-07 | 65 | 45 | 5 | SM00209 | |
| Domain | TSP1_rpt | 4.79e-07 | 65 | 45 | 5 | IPR000884 | |
| Domain | TSP1 | 4.79e-07 | 65 | 45 | 5 | PS50092 | |
| Domain | - | 7.26e-07 | 8 | 45 | 3 | 3.90.290.10 | |
| Domain | zf-C2H2_6 | 7.33e-07 | 314 | 45 | 8 | PF13912 | |
| Domain | TB | 1.09e-06 | 9 | 45 | 3 | PS51364 | |
| Domain | TB_dom | 1.09e-06 | 9 | 45 | 3 | IPR017878 | |
| Domain | EGF_CA | 1.95e-06 | 86 | 45 | 5 | PF07645 | |
| Domain | Znf-4CXXC_R1 | 5.68e-06 | 2 | 45 | 2 | IPR018866 | |
| Domain | zf-4CXXC_R1 | 5.68e-06 | 2 | 45 | 2 | PF10497 | |
| Domain | EGF | 1.27e-05 | 126 | 45 | 5 | PF00008 | |
| Domain | KRAB | 2.17e-05 | 358 | 45 | 7 | PF01352 | |
| Domain | KRAB | 2.64e-05 | 369 | 45 | 7 | SM00349 | |
| Domain | KRAB | 2.68e-05 | 370 | 45 | 7 | IPR001909 | |
| Domain | cEGF | 3.27e-05 | 26 | 45 | 3 | IPR026823 | |
| Domain | cEGF | 3.27e-05 | 26 | 45 | 3 | PF12662 | |
| Domain | Laminin_EGF | 8.11e-05 | 35 | 45 | 3 | PF00053 | |
| Domain | EGF_Lam | 8.11e-05 | 35 | 45 | 3 | SM00180 | |
| Domain | Laminin_EGF | 1.04e-04 | 38 | 45 | 3 | IPR002049 | |
| Domain | KRAB | 2.06e-04 | 358 | 45 | 6 | PS50805 | |
| Domain | Fol_N | 3.08e-04 | 11 | 45 | 2 | IPR003645 | |
| Domain | FOLN | 3.08e-04 | 11 | 45 | 2 | SM00274 | |
| Domain | ADAM_spacer1 | 1.39e-03 | 23 | 45 | 2 | IPR010294 | |
| Domain | ADAM_spacer1 | 1.39e-03 | 23 | 45 | 2 | PF05986 | |
| Domain | Peptidase_M12B_ADAM-TS | 1.51e-03 | 24 | 45 | 2 | IPR013273 | |
| Domain | EGF_LAM_2 | 2.37e-03 | 30 | 45 | 2 | PS50027 | |
| Domain | EGF_LAM_1 | 2.37e-03 | 30 | 45 | 2 | PS01248 | |
| Domain | LAM_G_DOMAIN | 3.78e-03 | 38 | 45 | 2 | PS50025 | |
| Domain | Peptidase_M12B_N | 3.97e-03 | 39 | 45 | 2 | IPR002870 | |
| Domain | Pep_M12B_propep | 3.97e-03 | 39 | 45 | 2 | PF01562 | |
| Domain | DISINTEGRIN_1 | 4.18e-03 | 40 | 45 | 2 | PS00427 | |
| Domain | Laminin_G_2 | 4.18e-03 | 40 | 45 | 2 | PF02210 | |
| Domain | ADAM_MEPRO | 4.18e-03 | 40 | 45 | 2 | PS50215 | |
| Domain | DISINTEGRIN_2 | 4.18e-03 | 40 | 45 | 2 | PS50214 | |
| Domain | Reprolysin | 4.18e-03 | 40 | 45 | 2 | PF01421 | |
| Domain | Peptidase_M12B | 4.18e-03 | 40 | 45 | 2 | IPR001590 | |
| Domain | Disintegrin_dom | 4.38e-03 | 41 | 45 | 2 | IPR001762 | |
| Domain | LamG | 5.04e-03 | 44 | 45 | 2 | SM00282 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 4.15e-05 | 300 | 31 | 6 | M610 | |
| Pathway | REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES | 7.11e-05 | 37 | 31 | 3 | M27134 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 8.34e-05 | 39 | 31 | 3 | M27417 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 8.34e-05 | 39 | 31 | 3 | MM15165 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 1.20e-04 | 44 | 31 | 3 | M26969 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PLASMIN_MEDIATED_ACTIVATION_OF_LATENT_TGF_BETA | 1.30e-04 | 8 | 31 | 2 | M47850 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 4.38e-04 | 68 | 31 | 3 | M27303 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 1.73e-03 | 109 | 31 | 3 | MM15164 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 1.82e-03 | 111 | 31 | 3 | M27416 | |
| Pathway | REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES | 2.23e-03 | 32 | 31 | 2 | MM14854 | |
| Pubmed | Control of lung development by latent TGF-β binding proteins. | 1.79e-06 | 2 | 47 | 2 | 20945348 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | ZNF500 LAMA5 LTBP3 MAP1S MEGF8 ZNF865 LTBP4 TMEM8B ZNF408 ZNF316 | 1.79e-06 | 1105 | 47 | 10 | 35748872 |
| Pubmed | 3.32e-06 | 75 | 47 | 4 | 20637190 | ||
| Pubmed | Mouse EWSR1 is crucial for spermatid post-meiotic transcription and spermiogenesis. | 5.36e-06 | 3 | 47 | 2 | 34100066 | |
| Pubmed | 1.07e-05 | 4 | 47 | 2 | 15611103 | ||
| Pubmed | 1.07e-05 | 4 | 47 | 2 | 33175657 | ||
| Pubmed | The latent transforming growth factor beta binding protein (LTBP) family. | 1.07e-05 | 4 | 47 | 2 | 11104663 | |
| Pubmed | Hemicentin 1 influences podocyte dynamic changes in glomerular diseases. | 1.07e-05 | 4 | 47 | 2 | 29488390 | |
| Pubmed | 1.07e-05 | 4 | 47 | 2 | 30365547 | ||
| Pubmed | 1.07e-05 | 4 | 47 | 2 | 16157329 | ||
| Pubmed | 1.78e-05 | 5 | 47 | 2 | 19897194 | ||
| Pubmed | 3.74e-05 | 7 | 47 | 2 | 10930463 | ||
| Pubmed | 4.62e-05 | 146 | 47 | 4 | 27068509 | ||
| Pubmed | 4.98e-05 | 8 | 47 | 2 | 27339457 | ||
| Pubmed | 6.10e-05 | 56 | 47 | 3 | 19591821 | ||
| Pubmed | 7.99e-05 | 10 | 47 | 2 | 22911783 | ||
| Pubmed | Disparate levels of beta-catenin activity determine nephron progenitor cell fate. | 7.99e-05 | 10 | 47 | 2 | 29705331 | |
| Pubmed | 9.33e-05 | 175 | 47 | 4 | 28071719 | ||
| Pubmed | Dystroglycan organizes axon guidance cue localization and axonal pathfinding. | 1.61e-04 | 14 | 47 | 2 | 23217742 | |
| Pubmed | 1.71e-04 | 205 | 47 | 4 | 20436479 | ||
| Pubmed | 1.86e-04 | 15 | 47 | 2 | 17804598 | ||
| Pubmed | 2.40e-04 | 17 | 47 | 2 | 21983115 | ||
| Pubmed | ISL1-based LIM complexes control Slit2 transcription in developing cranial motor neurons. | 2.70e-04 | 18 | 47 | 2 | 27819291 | |
| Pubmed | Ezh2 orchestrates topographic migration and connectivity of mouse precerebellar neurons. | 3.01e-04 | 19 | 47 | 2 | 23307742 | |
| Pubmed | 3.01e-04 | 19 | 47 | 2 | 16054034 | ||
| Pubmed | Global genetic analysis in mice unveils central role for cilia in congenital heart disease. | 3.41e-04 | 100 | 47 | 3 | 25807483 | |
| Pubmed | Proteomics characterization of extracellular space components in the human aorta. | 3.51e-04 | 101 | 47 | 3 | 20551380 | |
| Pubmed | Extracellular matrix secretion by cardiac fibroblasts: role of microRNA-29b and microRNA-30c. | 3.54e-04 | 248 | 47 | 4 | 24006456 | |
| Pubmed | Schwann cell myelination requires integration of laminin activities. | 3.69e-04 | 21 | 47 | 2 | 22767514 | |
| Pubmed | Netrin 1 directs vascular patterning and maturity in the developing kidney. | 4.44e-04 | 23 | 47 | 2 | 37818607 | |
| Pubmed | 5.26e-04 | 25 | 47 | 2 | 29158444 | ||
| Pubmed | A G-quadruplex DNA structure resolvase, RHAU, is essential for spermatogonia differentiation. | 5.26e-04 | 25 | 47 | 2 | 25611385 | |
| Pubmed | 5.54e-04 | 118 | 47 | 3 | 21078624 | ||
| Pubmed | 5.69e-04 | 26 | 47 | 2 | 19060336 | ||
| Pubmed | Ca2+ homeostasis maintained by TMCO1 underlies corpus callosum development via ERK signaling. | 5.69e-04 | 26 | 47 | 2 | 35927240 | |
| Pubmed | Genetic link between renal birth defects and congenital heart disease. | 6.61e-04 | 28 | 47 | 2 | 27002738 | |
| Pubmed | 6.61e-04 | 28 | 47 | 2 | 20940229 | ||
| Pubmed | Overactive Wnt5a signaling disrupts hair follicle polarity during mouse skin development. | 7.59e-04 | 30 | 47 | 2 | 36305473 | |
| Pubmed | Molecular profiling of the vestibular lamina highlights a key role for Hedgehog signalling. | 8.11e-04 | 31 | 47 | 2 | 36971701 | |
| Pubmed | Nkx6-1 controls the identity and fate of red nucleus and oculomotor neurons in the mouse midbrain. | 8.11e-04 | 31 | 47 | 2 | 19592574 | |
| Pubmed | Activation of beta-catenin signaling programs embryonic epidermis to hair follicle fate. | 9.19e-04 | 33 | 47 | 2 | 18480165 | |
| Pubmed | Protein interactome reveals converging molecular pathways among autism disorders. | 9.34e-04 | 560 | 47 | 5 | 21653829 | |
| Pubmed | 9.75e-04 | 34 | 47 | 2 | 35341793 | ||
| Pubmed | 9.75e-04 | 34 | 47 | 2 | 20189936 | ||
| Pubmed | 1.07e-03 | 148 | 47 | 3 | 22898364 | ||
| Pubmed | 1.09e-03 | 36 | 47 | 2 | 20587546 | ||
| Pubmed | Epicardial cell shape and maturation are regulated by Wt1 via transcriptional control of Bmp4. | 1.22e-03 | 38 | 47 | 2 | 31624071 | |
| Interaction | LTBP2 interactions | 1.42e-06 | 85 | 46 | 5 | int:LTBP2 | |
| Interaction | FBLN2 interactions | 1.54e-05 | 66 | 46 | 4 | int:FBLN2 | |
| Interaction | NOTCH2 interactions | 4.51e-05 | 423 | 46 | 7 | int:NOTCH2 | |
| Cytoband | 19p13 | 3.54e-04 | 27 | 47 | 2 | 19p13 | |
| Cytoband | 7p22.1 | 1.08e-03 | 47 | 47 | 2 | 7p22.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19q13 | 1.31e-03 | 1192 | 47 | 6 | chr19q13 | |
| Cytoband | 19q13.43 | 3.63e-03 | 87 | 47 | 2 | 19q13.43 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | ZNF500 ZNF200 KLF17 ZNF630 ZNF776 PRDM9 ZFP90 ZNF865 ZNF446 ZNF408 ZNF697 ZNF316 ZNF646 | 5.84e-11 | 718 | 31 | 13 | 28 |
| GeneFamily | Latent transforming growth factor beta binding proteins | 1.70e-05 | 4 | 31 | 2 | 628 | |
| GeneFamily | Zinc fingers C2H2-type|PR/SET domain family | 3.81e-04 | 17 | 31 | 2 | 1197 | |
| GeneFamily | ADAM metallopeptidases with thrombospondin type 1 motif | 4.78e-04 | 19 | 31 | 2 | 50 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 6.48e-11 | 196 | 47 | 9 | M3008 | |
| Coexpression | NABA_CORE_MATRISOME | 1.30e-09 | 275 | 47 | 9 | M5884 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 1.69e-09 | 191 | 47 | 8 | MM17059 | |
| Coexpression | NABA_MATRISOME | LAMA5 SNED1 SLIT2 LTBP3 ADAMTS8 IGFBP2 HMCN1 MEGF8 EDIL3 ADAMTS2 LTBP4 FBN3 WNT9B | 1.92e-08 | 1026 | 47 | 13 | M5889 |
| Coexpression | NABA_CORE_MATRISOME | 2.54e-08 | 270 | 47 | 8 | MM17057 | |
| Coexpression | NABA_MATRISOME | LAMA5 SNED1 SLIT2 LTBP3 ADAMTS8 IGFBP2 HMCN1 MEGF8 EDIL3 ADAMTS2 LTBP4 WNT9B | 1.48e-07 | 1008 | 47 | 12 | MM17056 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C7_PROLIFERATING_SCHWANN_CELL | SLIT2 ADAMTS8 MEGF8 HPS5 CDCA7 NPB ZNF865 LTBP4 TMEM8B ZNF697 | 1.41e-05 | 1054 | 47 | 10 | M45798 |
| Coexpression | CHICAS_RB1_TARGETS_GROWING | 7.20e-05 | 242 | 47 | 5 | M2128 | |
| Coexpression | ANDERSON_BLOOD_CN54GP140_ADJUVANTED_WITH_GLA_AF_AGE_18_45YO_6HR_DN | 1.99e-04 | 63 | 47 | 3 | M41065 | |
| Coexpression | LIM_MAMMARY_STEM_CELL_UP | 2.05e-04 | 479 | 47 | 6 | M2573 | |
| Coexpression | TRAVAGLINI_LUNG_ALVEOLAR_FIBROBLAST_CELL | 2.14e-04 | 164 | 47 | 4 | M41676 | |
| Coexpression | LIM_MAMMARY_STEM_CELL_UP | 2.15e-04 | 483 | 47 | 6 | MM1082 | |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_k-means-cluster#3_top-relative-expression-ranked_500 | 4.73e-05 | 188 | 45 | 5 | gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_500_k3 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_1000 | 1.64e-04 | 967 | 45 | 9 | Facebase_RNAseq_e9.5_Maxillary Arch_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_1000 | 1.72e-04 | 973 | 45 | 9 | Facebase_RNAseq_e9.5_Olfactory Placode_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e10.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_1000 | 1.73e-04 | 974 | 45 | 9 | Facebase_RNAseq_ratio_e10.5_MandibularArch_vs_MaxillaryArch_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_1000 | 1.76e-04 | 976 | 45 | 9 | Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_1000 | 1.87e-04 | 984 | 45 | 9 | Facebase_RNAseq_e10.5_Olfactory Pit_1000 | |
| ToppCell | ASK440-Mesenchymal|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 5.03e-08 | 191 | 47 | 6 | f12959eebb4167e1aa03de05d7711a702c58b3c9 | |
| ToppCell | human_hepatoblastoma-Hepatic_Stellate_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | 5.03e-08 | 191 | 47 | 6 | 78c3c2fdb68c3407f2436f90e1e6a780bbf8b79e | |
| ToppCell | ASK440-Mesenchymal-Fibroblast|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 5.03e-08 | 191 | 47 | 6 | 387296b5377ef6839f0812e5b3529a10b5f7d530 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.18e-08 | 192 | 47 | 6 | dcd924d6eb67d33ee9f5d3e8ab6e1d4283d6b708 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.35e-08 | 193 | 47 | 6 | b3ad5ff480d99217f36cc7471e5a96a519ddb409 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.35e-08 | 193 | 47 | 6 | fb28717fadd06c3840636d25409ce80c9254bd34 | |
| ToppCell | Mesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor | 5.35e-08 | 193 | 47 | 6 | acad568621ed677031797b8c2e34dafea798d681 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.51e-08 | 194 | 47 | 6 | 011e14d9ed1393275f892060e7708ffadcd0767f | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.51e-08 | 194 | 47 | 6 | 60622bd2f75bfe4c37f721cb12f03dab33f2f58d | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.51e-08 | 194 | 47 | 6 | 89b706af2b25991fc2707eb24f49ba6ff3ae01f7 | |
| ToppCell | Mesenchymal|World / Lineage, Cell type, age group and donor | 6.41e-08 | 199 | 47 | 6 | 4bac110c2b3609f6ee5d0e3275da0824a6240270 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.19e-06 | 177 | 47 | 5 | 452ec2df36c6d656a7cdadc55be545ccdb146a29 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.52e-06 | 186 | 47 | 5 | 77bebf576eb9b96ecb4fefb8a82a31aaaa917fc0 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.52e-06 | 186 | 47 | 5 | 13bc41c60fd628af31899a5e8b480e06cc4781be | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 1.57e-06 | 187 | 47 | 5 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D175|Adult / Lineage, Cell type, age group and donor | 1.57e-06 | 187 | 47 | 5 | e15d2967aac248da3517bc2c7d1beaa1d5a0aa7f | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.65e-06 | 189 | 47 | 5 | a153b83314cf52808f685296cff8c95af3f4983d | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.65e-06 | 189 | 47 | 5 | 2a22b9fae70afb3dab8476f9c00e48a4df756410 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.69e-06 | 190 | 47 | 5 | d60395739458d7f47a3350ade751fe3819500320 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.74e-06 | 191 | 47 | 5 | b13229bb7f3713a392271aaf5dbae3edd1b9fe5a | |
| ToppCell | droplet-Lung-1m-Mesenchymal-fibroblast-alveolar_fibroblast|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.74e-06 | 191 | 47 | 5 | d04e6292fef189b8d8ed0f4b0c310b2b250fd30e | |
| ToppCell | droplet-Lung-1m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l49|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.74e-06 | 191 | 47 | 5 | de3e9b704621b26836c2ddc39fa3e840dfb4541b | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.74e-06 | 191 | 47 | 5 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.78e-06 | 192 | 47 | 5 | 25492568f9cbe097b7bb1db50d8b817c80ea87d7 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.78e-06 | 192 | 47 | 5 | f4fc2b0121f879bab2bee99dfb5ff2c3ca1c0e1b | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.78e-06 | 192 | 47 | 5 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | LPS_only-Stromal_mesenchymal|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.78e-06 | 192 | 47 | 5 | 162d8b5858d150ecbbd1c9bf2b19c6c9cd50a158 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.78e-06 | 192 | 47 | 5 | de9c1536d5aee86f9c62acbc54ca8fa581c00f17 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.78e-06 | 192 | 47 | 5 | ee085e04d5dcfb657522484ed20b8c1ddeccfe0c | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.78e-06 | 192 | 47 | 5 | deeecd26972241846b4cb998edf0c7a87ff0c4df | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.83e-06 | 193 | 47 | 5 | 9f69edc97b868d23998abc98928a2e89a885ef8a | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.83e-06 | 193 | 47 | 5 | 99525545552b371c86b18b6ea6f4897dc6e9a9ec | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D231|Adult / Lineage, Cell type, age group and donor | 1.83e-06 | 193 | 47 | 5 | ef2f456c094e6e3c6ee81e0668c953cb8d0e1c0a | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.87e-06 | 194 | 47 | 5 | 71d3c7448b1734de54187f902f65649f9283bd4c | |
| ToppCell | COVID-19-Heart-Fib_2|Heart / Disease (COVID-19 only), tissue and cell type | 1.87e-06 | 194 | 47 | 5 | d91c9f2ec47319051fc398320693fddbe8bbd4d6 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.87e-06 | 194 | 47 | 5 | 6e13549f697f7478b34fe71f7dd9d63c5d3db22e | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell|Adult / Lineage, Cell type, age group and donor | 1.92e-06 | 195 | 47 | 5 | 61c9e09fc84d1012e472185d70ad0a06cee30d6e | |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | 1.92e-06 | 195 | 47 | 5 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D122|Adult / Lineage, Cell type, age group and donor | 1.92e-06 | 195 | 47 | 5 | aa0add081881d349099d12efca5cdee098038d4e | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.97e-06 | 196 | 47 | 5 | 9737a5f006d37b549f281e1863aca558e1e4dc99 | |
| ToppCell | Children_(3_yrs)-Mesenchymal|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.97e-06 | 196 | 47 | 5 | bc94909f9b2dc08a59eef1914148b69720569c8f | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.97e-06 | 196 | 47 | 5 | cecf82cd5e0a3835d655f5e7478578674a63ce25 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.97e-06 | 196 | 47 | 5 | 7d8505dac15fa59935ccf592afc54b04c4c6554f | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.02e-06 | 197 | 47 | 5 | 94a9603cbd3516fbcce871909693b88f20d41713 | |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | 2.02e-06 | 197 | 47 | 5 | f1c8936986123a3151140c374fcd62d6705c530b | |
| ToppCell | COVID-19-lung-Fibroblast|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.07e-06 | 198 | 47 | 5 | 3ec01a55ade5e1627258cc3cfebb2c3207a4cb43 | |
| ToppCell | Adult-Mesenchymal|Adult / Lineage, Cell type, age group and donor | 2.07e-06 | 198 | 47 | 5 | 26e55b409db2a1637c95fae7c54b0abea1ef550c | |
| ToppCell | COVID-19-lung-Fibroblast|lung / Disease (COVID-19 only), tissue and cell type | 2.07e-06 | 198 | 47 | 5 | df3de77216f5c5d6141ec44d01c56b942f611838 | |
| ToppCell | nucseq-Mesenchymal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.07e-06 | 198 | 47 | 5 | 8f52243ca8b9ba68a75ae411506a3a6de258eb97 | |
| ToppCell | background-Hepatic_Stellate_cells|background / Sample and Cell Type and Tumor Cluster (all cells) | 2.07e-06 | 198 | 47 | 5 | bd11b0e9e80449aab979a02c1023e0638c431c7c | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.07e-06 | 198 | 47 | 5 | 21cf4d81386761d09d0f6829c01c198e5524176d | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.07e-06 | 198 | 47 | 5 | f1374f7a50244d59c766ac41f44c08c9117407d2 | |
| ToppCell | proximal-mesenchymal-Alveolar_Fibroblast|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.12e-06 | 199 | 47 | 5 | 7f4840ae6a888380feca722543e5e52783f3e35d | |
| ToppCell | distal-mesenchymal-Alveolar_Fibroblast-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.12e-06 | 199 | 47 | 5 | 28c1722deef3b8347371c7359be7c64b95780de3 | |
| ToppCell | proximal-3-mesenchymal-Alveolar_Fibroblast|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.12e-06 | 199 | 47 | 5 | 301d02bbb37e6f1d24b6e865bc3fe3e91260eb30 | |
| ToppCell | Biopsy_Control_(H.)-Mesenchymal-Myofibroblasts|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 2.12e-06 | 199 | 47 | 5 | 7a227c239afdaebcac84644d9b2653a5f1a4be71 | |
| ToppCell | proximal-mesenchymal-Alveolar_Fibroblast-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.12e-06 | 199 | 47 | 5 | 9a16e519fb0651a7c4d8e05b931df4fb3b0eb3d1 | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic-Fibroblastic_2|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.12e-06 | 199 | 47 | 5 | 66a79732caf2f04c09b4d9832377aa01ca477677 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-G|343B / Donor, Lineage, Cell class and subclass (all cells) | 2.12e-06 | 199 | 47 | 5 | f4b6c095cbe7a38b310adc49be4069e4d56e6a66 | |
| ToppCell | distal-mesenchymal-Alveolar_Fibroblast|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.12e-06 | 199 | 47 | 5 | 655d07cf9a2fd9b945a2ed4f824cba0297de72a8 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-G-|343B / Donor, Lineage, Cell class and subclass (all cells) | 2.12e-06 | 199 | 47 | 5 | 9c6d1c328bfbb6547f4c7bb2a784576a56bd72af | |
| ToppCell | Biopsy_Other_PF-Mesenchymal-Myofibroblasts|Biopsy_Other_PF / Sample group, Lineage and Cell type | 2.18e-06 | 200 | 47 | 5 | e504570fd7eec1524c401b1cfa9d10822d80d994 | |
| ToppCell | medial-mesenchymal-Alveolar_Fibroblast|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.18e-06 | 200 | 47 | 5 | c22cbfecee00183dd4be678f116ab9fd9ad0a4dd | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.18e-06 | 200 | 47 | 5 | e8462395fee0a532d1e7ec7f1795f28c42af6541 | |
| ToppCell | medial-2-mesenchymal-Alveolar_Fibroblast|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.18e-06 | 200 | 47 | 5 | cc6062dac07916c29091fc6bee2b864d29e6525b | |
| ToppCell | medial-mesenchymal-Alveolar_Fibroblast-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.18e-06 | 200 | 47 | 5 | 5c0716bf375c8158f7dc2c82bf5eaf37af594dd0 | |
| ToppCell | 10x5'v1-week_17-19-Mesenchymal_osteo-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.18e-06 | 200 | 47 | 5 | 3c898e81444b001835c3f1bbc68183078701b135 | |
| ToppCell | Parenchymal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.18e-06 | 200 | 47 | 5 | cf433f9b43d7db07acaf70e060f8f77c974e72f3 | |
| ToppCell | 10x5'v1-week_17-19-Mesenchymal_osteo|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.18e-06 | 200 | 47 | 5 | 3eca8ffeb41b664fbdbbd70b375c5d953503ab29 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.18e-06 | 200 | 47 | 5 | 311fab076f2ceb258e3970eb21e39344b894042a | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.18e-06 | 200 | 47 | 5 | 34f52003988ce6329d8deeee1ab875fa77e01e9d | |
| ToppCell | cellseq2-Mesenchymal-Fibroblastic|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.18e-06 | 200 | 47 | 5 | 1c10597edd532bf172ca09870a937d35e2585081 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.33e-05 | 137 | 47 | 4 | 85b3a98039c1f68addad0334aa5b2584f6045aaa | |
| ToppCell | BAL-Mild-Myeloid-MoAM-MoAM2|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.05e-05 | 153 | 47 | 4 | 5fbb90b8477f9fdabf3be19efd3068fbf70abee6 | |
| ToppCell | BAL-Mild-Myeloid-MoAM-MoAM2-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.05e-05 | 153 | 47 | 4 | 2c46183481e6d5a7fa190a743062509465f88e56 | |
| ToppCell | BAL-Mild-Myeloid-MoAM-MoAM2|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.05e-05 | 153 | 47 | 4 | decc4f3098a9374a6b65c015a9d36380986290bf | |
| ToppCell | BAL-Mild-Myeloid-MoAM-MoAM2-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.05e-05 | 153 | 47 | 4 | 36a28805c0545c2f410c74a6ca0a70d840e75715 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.32e-05 | 158 | 47 | 4 | 7960337d87afecf2692ab65e5991f052ceddfacc | |
| ToppCell | PND03-Immune-Immune_Myeloid-DC-cDC2-cDC2_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.95e-05 | 168 | 47 | 4 | cc0dd43d5cda01e643d8e8d74ec7617d61890760 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.46e-05 | 175 | 47 | 4 | 795a6564d5a75ffd35d39f5274b9e8d28708bbc8 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-G|356C / Donor, Lineage, Cell class and subclass (all cells) | 3.62e-05 | 177 | 47 | 4 | 8220cc2fc0ee8764a67a3be51d75248be2453040 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-G-|356C / Donor, Lineage, Cell class and subclass (all cells) | 3.62e-05 | 177 | 47 | 4 | 7617270f49cd6b7ba66db72d20560cee985012b2 | |
| ToppCell | droplet-Liver-hepatocytes-3m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.62e-05 | 177 | 47 | 4 | 8ef41ee5d63737b810ad7371b0437625e7e1badf | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.78e-05 | 179 | 47 | 4 | 948c2a01ec7a626c68281e6e796a9f0527a88591 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.78e-05 | 179 | 47 | 4 | 666072c0e8448dbaec1683d18368ec2502453f90 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.95e-05 | 181 | 47 | 4 | 451b87ac95154bb80018b8dd245b4a6389d81411 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Degenerative_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.95e-05 | 181 | 47 | 4 | 6d1f1ad35778a2a227f966f11f6edd8e89452576 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.95e-05 | 181 | 47 | 4 | e0abf2707d9e0aa942c657eef7d2cbcd02f060dd | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.03e-05 | 182 | 47 | 4 | 5f513bbb7125956eb528e3120de3fd776770a7c3 | |
| ToppCell | 390C-Lymphocytic-CD4_T-cell-Treg_cell_3|390C / Donor, Lineage, Cell class and subclass (all cells) | 4.12e-05 | 183 | 47 | 4 | 228092290dbb08785c4eda224e3ad03e99e10fab | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.12e-05 | 183 | 47 | 4 | 2e831a4d99c6f983793df71c0994124c943c6da9 | |
| ToppCell | 3'-Distal_airway-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.30e-05 | 185 | 47 | 4 | 7b1c5d99bd7a6e148524029758cee244a17f5d09 | |
| ToppCell | 3'-Distal_airway-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.30e-05 | 185 | 47 | 4 | e9033a03d574956cf3ae228740b3166e40a6397f | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell-D231|Adult / Lineage, Cell type, age group and donor | 4.30e-05 | 185 | 47 | 4 | fb6bd7e849ecf4ed9cd9c4e2a946a2d12d62f804 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.30e-05 | 185 | 47 | 4 | bdd2e6cb20294b39a9d856004bf57ba69cf877e2 | |
| ToppCell | 3'-Distal_airway-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.30e-05 | 185 | 47 | 4 | 578f12c6b2e33d09598dc8e022a20c8555d1325c | |
| ToppCell | human_hepatoblastoma-Hepatic_Stellate_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 4.39e-05 | 186 | 47 | 4 | cb1fc4b9140666b43415e21c9b434dc9b144e9d0 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.39e-05 | 186 | 47 | 4 | 5473283fb95cee556b1f6934cf72169b676b5bcc | |
| ToppCell | COVID-19-Heart-Fib_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.58e-05 | 188 | 47 | 4 | fe361215f4ba841aa5e1e581fb56f2f4d3ccd201 | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Lobular_Carcinoma-6|TCGA-Breast / Sample_Type by Project: Shred V9 | 4.58e-05 | 188 | 47 | 4 | c90669b51e1902fe7726555290c91c92a911df83 | |
| Disease | cystic kidney disease (implicated_via_orthology) | 1.02e-04 | 10 | 45 | 2 | DOID:2975 (implicated_via_orthology) | |
| Disease | pulse pressure measurement | 2.15e-04 | 1392 | 45 | 9 | EFO_0005763 | |
| Disease | vital capacity | 5.02e-04 | 1236 | 45 | 8 | EFO_0004312 | |
| Disease | response to radiation, Hematuria | 5.64e-04 | 23 | 45 | 2 | GO_0009314, HP_0000790 | |
| Disease | RS-10-hydroxywarfarin to RS-warfarin ratio measurement | 6.38e-04 | 110 | 45 | 3 | EFO_0803335 | |
| Disease | visceral heterotaxy (implicated_via_orthology) | 1.46e-03 | 37 | 45 | 2 | DOID:0050545 (implicated_via_orthology) | |
| Disease | optic cup area measurement | 3.32e-03 | 56 | 45 | 2 | EFO_0006940 | |
| Disease | radiation-induced disorder | 4.72e-03 | 67 | 45 | 2 | EFO_0009565 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| TLRGIRKCPRCGTYN | 21 | Q9NWW7 | |
| RKCPRCGTYNGTRGL | 26 | Q9NWW7 | |
| GGRYCLGRRAKYQSC | 561 | Q9UP79 | |
| VPGSYRCTCRQGFAG | 1341 | Q75N90 | |
| SGCSVRRRPYGCVLR | 6 | P32970 | |
| GGGSQFTKYGCRRRL | 871 | O95450 | |
| VGCQGSRSELRGYPC | 416 | Q6ZRP7 | |
| TSGGFLRLGRPCCYI | 231 | Q66K74 | |
| GRCSGGQQPLIYCAR | 226 | Q9UPZ3 | |
| EACGVYTPRCGQGLR | 96 | P18065 | |
| FRGPSCQRSCQPGRY | 601 | Q5VY43 | |
| CQRSCQPGRYGKRCV | 606 | Q5VY43 | |
| SYLPLRCMAGGCGRL | 2096 | Q7Z7M0 | |
| RGQFCGPCLRNRYGE | 376 | Q96GN5 | |
| KPCPGLAYEQRRCTG | 236 | P27918 | |
| AGGLCRCRPGYTGTA | 646 | O15230 | |
| RGGRTQCLCKPGYAG | 1931 | O15230 | |
| YRCVCPRGYRSQGVG | 5296 | Q96RW7 | |
| PYVCRECGRGFRNKS | 831 | Q9NQV7 | |
| RAGYCLSLDCGLRGP | 371 | P81408 | |
| RGDTFIGYVCKCPRG | 96 | O43854 | |
| LGRAAQGGCPRARCR | 51 | Q9GZZ7 | |
| YRNPLTGLCRIGGDC | 296 | Q8NCG7 | |
| GSYRCLCPQGHRLVG | 846 | Q9NS15 | |
| ACRPGRCVNLPGSYR | 1091 | Q9NS15 | |
| LCGRGACKNLPGSFR | 681 | Q8N2S1 | |
| GTGRRGSSEARPYCC | 271 | Q5JT82 | |
| LCVPCKRGCNLRGGR | 181 | Q8NAJ2 | |
| RCERLPDGRGTYQCK | 96 | Q8NG41 | |
| RNGGSCRNLPGAYVC | 801 | Q8TER0 | |
| GVRGQFCGPCLRNRY | 291 | Q9BWT1 | |
| VCGGCYLGKSTRRRA | 146 | Q8NAA6 | |
| GCCSSNGRRRPRAGI | 146 | O60930 | |
| TEQRPYRCGVCGRGF | 871 | P0CJ78 | |
| GPAGSSPKQGRRYRC | 341 | Q9H9D4 | |
| SPKQGRRYRCGECGK | 346 | Q9H9D4 | |
| PFRCNQCGKTYRHGG | 1051 | O15015 | |
| CAGGQCCGPLRSKRR | 1486 | O94813 | |
| PSGARARGCGYQLCI | 436 | A6NDV4 | |
| ERPYGCKKCGRRFGR | 361 | P98182 | |
| RFRCGRPPKYNASCS | 206 | Q2M218 | |
| ATPRKPYTCEQCGRG | 326 | Q9NWS9 | |
| PYVCRECGKGFGRNS | 436 | Q5TEC3 | |
| RPYACGECGRRFGQS | 801 | A6NFI3 | |
| CGLQLSGEEGRRCYP | 386 | A6NIX2 | |
| CRPSKYSPGTAGRVC | 291 | O14905 | |
| CGRGYQKRTRTCTNP | 276 | O95185 | |
| PYTCPACGRGFRRGT | 436 | O60304 | |
| CCVYRPLKFRGGNRT | 346 | Q9NQA5 | |
| KPYRCNLCGRSFRHG | 336 | Q8TF47 | |
| GCCGRHGNRPVRYCK | 391 | Q9P2D8 | |
| GVRTGKRPYQCGQCD | 256 | Q68DI1 | |
| KRRSKGDRCYNCGGL | 131 | Q9H9Z2 |